Regional Health Properties, Inc. | 10-Q: FY2025 Q2 Revenue: USD 10.06 M

Revenue: As of FY2025 Q2, the actual value is USD 10.06 M.

EPS: As of FY2025 Q2, the actual value is USD -0.68.

EBIT: As of FY2025 Q2, the actual value is USD -406 K.

Rental Revenues: $1.3 million for the three months ended June 30, 2025, compared to $1.8 million for the same period in 2024, a decrease of 28.7%.
General and Administrative Expenses: $0.7 million for the three months ended June 30, 2025, compared to $0.9 million for the same period in 2024, a decrease of 16.3%.
Depreciation and Amortization: $0.3 million for the three months ended June 30, 2025, compared to $0.4 million for the same period in 2024, a decrease of 21.6%.
Credit Loss Expense: $0.2 million for the three months ended June 30, 2025, compared to $0.0 million for the same period in 2024.

Patient Care Revenues: $8.8 million for the three months ended June 30, 2025, compared to $2.5 million for the same period in 2024, an increase of 247.5%.
Patient Care Expenses: $7.2 million for the three months ended June 30, 2025, compared to $2.2 million for the same period in 2024, an increase of 229.1%.
General and Administrative Expenses: $1.7 million for the three months ended June 30, 2025, compared to $0.4 million for the same period in 2024, an increase of 374.9%.
Depreciation and Amortization: $0.1 million for the three months ended June 30, 2025, compared to $0.1 million for the same period in 2024.
Credit Loss Expense: $0.2 million for the three months ended June 30, 2025, compared to $0.0 million for the same period in 2024.

Net Cash Provided by Operating Activities: $0.8 million for the six months ended June 30, 2025, compared to $1.1 million for the same period in 2024.
Net Cash Used in Investing Activities: $0.4 million for the six months ended June 30, 2025, compared to $0.4 million for the same period in 2024.
Net Cash Used in Financing Activities: $0.7 million for the six months ended June 30, 2025, compared to $1.3 million for the same period in 2024.

Core Business Focus: The company plans to grow its operations, streamline its cost infrastructure, and increase liquidity through refinancing or repaying debt, increasing lease revenue, modifying lease terms, replacing non-performing tenants, reducing general and administrative expenses, and executing the proposed merger with SunLink Health Systems, Inc.
Non-Core Business: The company has committed to a plan to sell certain assets held for sale to increase cash available for operations and future investments.
Priority: The company anticipates net principal repayments of approximately $3.3 million during the next twelve-month period, including $2.7 million of routine debt service amortization, $0.4 million of insurance financing amortization, and a $0.2 million payment of bond debt.

The company continues to move toward closing the merger with SunLink Health Systems, Inc., which has been approved by both companies’ boards of directors and remains subject to shareholder approvals, regulatory clearance, and other customary closing conditions.
The company has received and evaluated unsolicited acquisition proposals but determined that they did not constitute a “Superior Regional Proposal.”
The company experienced changes in its listing status, with its common stock and Series A Preferred Stock now trading on the OTC Markets under the symbols “RHEP” and “RHEPA,” respectively.